The Cobra Perilaryngeal Airway (PLA) provides better sealing pressure than the Laryngeal Mask Airway Unique (LMAU) during positive-pressure ventilation in adults. We compared the performance of the CobraPLA and LMAU in infants and children. METHODS: Two-hundred pediatric patients were randomly assigned to a CobraPLA or an Laryngeal Mask Airway (LMA). We measured airway sealing at cuff inflation pressures of 40 and 60 cm H 2 O; ease and time of insertion; device stability; efficacy of ventilation; number of insertion attempts; incidence of postoperative sore throat, dysphonia, laryngospasm, bronchospasm, and gastric gas insufflation. Steady-state end-tidal CO2 was measured at the head of the CobraPLA and at the "Y-piece" piece of the anesthetic circuit. For the major outcomes, the airway groups were subdivided post hoc into small and large CobraPLA and small and large LMA subgroups. Results are presented as means Ϯ sds; P Ͻ 0.05 was considered statistically significant. RESULTS: Airway sealing pressure with the cuff inflated to 60 cm H 2 O in the large CobraPLA subgroup (22 Ϯ 7 cm H 2 O) was significantly more than that of the small CobraPLA subgroup (18 Ϯ 5 cm H 2 O) and large LMA subgroup (16 Ϯ 5 cm H 2 O; P Ͻ 0.001). The CobraPLA was more stable than the LMA (same anatomic fit score before and after surgery) and produced less gastric insufflation. Head CobraPLA end-tidal CO2 values were 6.4 Ϯ 6 mm Hg more than those of the Y piece of the circle circuit. CONCLUSIONS: The CobraPLA airway performed as well as the LMAU during anesthesia in pediatric patients for a large range of outcomes and was superior for some.
BACKGROUND:
The Cobra Perilaryngeal Airway (PLA) provides better sealing pressure than the Laryngeal Mask Airway Unique (LMAU) during positive-pressure ventilation in adults. We compared the performance of the CobraPLA and LMAU in infants and children. METHODS: Two-hundred pediatric patients were randomly assigned to a CobraPLA or an Laryngeal Mask Airway (LMA). We measured airway sealing at cuff inflation pressures of 40 and 60 cm H 2 O; ease and time of insertion; device stability; efficacy of ventilation; number of insertion attempts; incidence of postoperative sore throat, dysphonia, laryngospasm, bronchospasm, and gastric gas insufflation. Steady-state end-tidal CO2 was measured at the head of the CobraPLA and at the "Y-piece" piece of the anesthetic circuit. For the major outcomes, the airway groups were subdivided post hoc into small and large CobraPLA and small and large LMA subgroups. Results are presented as means Ϯ sds; P Ͻ 0.05 was considered statistically significant. RESULTS: Airway sealing pressure with the cuff inflated to 60 cm H 2 O in the large CobraPLA subgroup (22 Ϯ 7 cm H 2 O) was significantly more than that of the small CobraPLA subgroup (18 Ϯ 5 cm H 2 O) and large LMA subgroup (16 Ϯ 5 cm H 2 O; P Ͻ 0.001). The CobraPLA was more stable than the LMA (same anatomic fit score before and after surgery) and produced less gastric insufflation. Head CobraPLA end-tidal CO2 values were 6.4 Ϯ 6 mm Hg more than those of the Y piece of the circle circuit. CONCLUSIONS: The CobraPLA airway performed as well as the LMAU during anesthesia in pediatric patients for a large range of outcomes and was superior for some. Si nce its introduction into anesthesia practice in 1988, the Laryngeal Mask Airway (LMA, The Laryngeal Mask Company Limited, Henley-on-Thames, UK) has been used in 150 million cases worldwide and has proved to be safe and effective in both adult and pediatric patients. 1 Nevertheless, more than one insertion attempt is required in 5% to 10% of all cases 2 ; furthermore, the LMA does not provide a reliable airtight seal around the larynx, and pressures of 15 to 20 cm H 2 O usually cause gas leakage. 3 Consequently, the device often functions poorly during positivepressure ventilation.
Despite these minor problems, the LMA is currently used in many surgical patients, including those undergoing nonconventional surgeries (laparotomies or laparoscopies) 2, 4 and is part of the ASA difficult airway algorithm. 5 The Cobra Perilaryngeal Airway (CobraPLA)(Engineered Medical Systems, Indianapolis, IN) was introduced into clinical practice in 2003 as a disposable extraglottic airway device. In adults, insertion time and performance characteristics were similar to the LMA, while airway-sealing pressures were greater: 23 Ϯ 6 cm H 2 O vs 18 Ϯ 5 cm H 2 O. 6 Several reports have shown the usefulness of the CobraPLA in pediatric patients [7] [8] [9] [10] ; however, the device has yet to be fully evaluated in infants and children. Our goal was thus to evaluate the use of CobraPLA in routine clinical practice in pediatric patients and compare its performance with the Laryngeal Mask Airway Unique (LMAU). Our primary outcome was the airway sealing pressure; secondary outcomes were ease and time for insertion, position and stability of the device, number of insertion attempts, incidence of gastric insufflation and of postoperative complications. Furthermore, in a subset of patients, we used a specially designed CobraPLA with a gas sampling site near the head of the device to test the hypothesis that the end-tidal CO 2 (ETco 2 ) and end-tidal sevoflurane (ET sevo ) concentrations measured at the "head" of the CobraPLA are greater (and presumably more accurate) than those measured at the "Y-piece" of the anesthetic circuit.
METHODS
With approval of the IRB at the University of Texas Medical School at Houston and written parental consent, 200 pediatric patients, ASA physical status I-II, 0 to 12-yr-old were enrolled in this prospective, randomized, single-blind study. The patients were scheduled for elective orthopedic and urological procedures with an estimated duration of anesthesia under 2 h. Patients with known gastrointestinal reflux, sore throat or upper respiratory airway infection, and with known or suspected difficult airways were excluded from the study.
The CobraPLA comprises a breathing tube with a widened distal end. When the cuff of the CobraPLA is inflated it seals the distal end from the upper airway, thereby allowing positive-pressure ventilation. The distal Cobra head holds both soft tissues and the epiglottis away from the airway opening, thus allowing unimpeded ventilation. (Fig. 1) The CobraPLA is manufactured in eight sizes; four of them (0.5-2) are suitable for pediatric patients.
Anesthetic Protocol
All patients older than 10 mo were premedicated with oral midazolam, 0.5 mg/kg up to maximum of 15 mg. General anesthesia was induced with sevoflurane in a mixture of 30/70% O 2 /N 2 O through a facemask. An IV catheter was inserted and 1 mg/kg propofol and 1 g/kg fentanyl were administered.
Both devices were lubricated with a water-based lubricant. Randomization to one of the airway devices (including anatomical fit and ET co2 subgroups) was based on computer-generated codes maintained in sequentially numbered opaque envelopes which were opened just before device insertion. Insertion of the device was attempted when the eyelash reflex had disappeared and the jaw was relaxed at least 60 sec after propofol administration. The LMAU was inserted with a partially inflated cuff. No muscle relaxants were administered before airway insertion.
LMAU and CobraPLA sizes were selected based on manufacturer's recommendations, modified to avoid overlap of the weight groups. LMAU: Size 1 (Յ5 kg), Size 1.5 (6 -10 kg); Size 2 (11-20 kg), and Size 2.5 (21-30 kg). CobraPLA: Size 1/2 (2.5-7.5 kg); Size 1 (7.5-15 kg); Size 1.5 (16 -30 kg); and Size 2 (31-60 kg). All the investigators had years of experience with use of the LMAU and at least 20 insertions with the CobraPLA.
Failure to properly position an airway was defined by any one of the following: 1) inability to obtain an ET co2 waveform; 2) presence of an audible air leak at 10 cm H 2 O-peak inspiratory pressure; 3) an expired tidal volume Ͻ4 mL/kg; 4) signs of airway obstruction (peak airway pressure Ͼ25 cm H 2 O with low expired tidal volumes); or, 5) an Spo 2 Ͻ93% with an Fio 2 of 100%. If insertion failed, the following algorithm was pursued: (a) two attempts with the randomly assigned airway, (b) insertion of a smaller size study device; (c) a single insertion attempt with the alternative airway device; (d) 0.6 mg/kg IV rocuronium and tracheal intubation. The attending anesthesiologists were free to intubate the patient's trachea at any time if clinically indicated.
Anesthesia was maintained with 60
, and sevoflurane was needed to maintain the mean arterial blood pressure within 20% of the preinduction value. In longer surgeries (Ͼ45 min), the patients' lungs were mechanically ventilated with a tidal volume of 8 mL/kg at a rate sufficient to maintain ET co2 near 40 mm Hg and then allowed to resume spontaneous ventilation towards the end of the procedure. If the delivered 8 mL/kg tidal volume produced airway pressure in excess of 20 cm H 2 O, tidal volume was reduced as necessary to maintain lower peak airway pressures. Fresh gas flow was maintained at a constant rate of 3 L/min.
Airway device insertion depth was defined by the distance from the tip of the device to a mark made at the level of the incisors after insertion. After device insertion, the patient's head was maintained in neutral CobraPLA with CO 2 sampling prototype: end tidal CO 2 sampling tube (6) which opens at the head of the device (7).
position by rolls positioned bilaterally. All devices were examined upon removal for gross blood staining. Perioperative complications such as laryngospasm and bronchospasm were recorded both intra and postoperatively.
Measurements
Each device was evaluated by assessing the following variables: positioning, gas leak at 60 and 40 cm H 2 O cuff pressures, anatomical fit, gastric insufflation, and the degree of pharyngeal irritation. Standard anesthetic safety data were also recorded, including arterial blood pressure, heart rate, oxyhemoglobin saturation, peak airway pressure, and total amount of fentanyl administered.
Time for successful airway insertion was measured by an independent observer beginning when the tip of the device was at the level of the incisors and ending after all the following were completed: the cuff was inflated, the breathing circuit was connected to the airway, an ETco 2 trace was detected, a tidal volume of more than 4 mL/kg body weight was measured, and no air leak was detected at a peak inspiratory positive airway pressure ventilation of 15 cm H 2 O. The number of attempts, the initial airway size and the size ultimately used were recorded. Once the device was optimally positioned, it was taped and its position was not altered unless clinically necessary.
Ease of Insertion
Ease of airway insertion was evaluated qualitatively, using the following scale: 1) smooth insertion without any need for adjustment; 2) need for at least one adjustment maneuver, and 3) more than one adjustment maneuver required to obtain adequate positioning.
Airway sealing pressure was measured by closing the expiratory valve of the circle system at 3 L/min gas flow and recording the airway pressure at which the dial on the aneroid manometer reached equilibrium.
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Assessment of airway sealing pressure was initially performed with the device's cuff inflated to 60 cm H 2 O followed immediately by measurement at 40 cm H 2 O. Subsequently, the cuff was fully deflated, an orogastric tube (OGT) was passed into the stomach to remove any air that entered during the assessment period. The OGT was then removed and the device's cuff reinflated, monitored with a manometer (Mallinckrodt) and maintained at 40 cm H 2 O throughout the procedure.
In a random subgroup of patients from both groups, a flexible fiberoptic bronchoscope (Olympus BFP 30, O.D. 5.0 mm, Tokyo, Japan) was inserted through the device via a connector with a self-sealing diaphragm up to the mask aperture bars both before and at the end of the surgery. The airway position was scored as follows 12 : 4 ϭ only vocal cords visible; 3 ϭ vocal cords plus posterior epiglottis visible; 2 ϭ vocal cords plus anterior epiglottis visible; 1 ϭ vocal cords not fiberoptically visible.
At the end of surgery with the patient deeply anesthetized, the cuff of the device was deflated, an OGT was inserted under direct vision using a tong blade depressor and gas was aspirated from the stomach using a 60-mL syringe. 13 The amount of gas aspirated was recorded for each device. The position of the OGT was confirmed by the presence of gastric content at aspiration. If nothing was aspirated, 2 mL of air was injected while listening over the epigastrium to confirm the tube's position and clear any blockage. These 2 mL of air were then aspirated and omitted from calculations. Difficulties with the OGT insertion, if any, were noted. The oral cavity and part of the pharynx were inspected for blood or trauma before and after the placement of the OGT.
One and 24 h postoperatively, the patient's parents (blinded to group assignment) were asked to rate the presence of dysphonia (Yes/No). Sore throat was assessed as present or absent (when age and willingness allowed the patients to respond) 1 h postoperatively.
A specially designed CobraPLA prototype with an ETco 2 sampling site ( Fig. 1 ) that opened at the head of the device was used in a subset of patients. Once steady-state was reached (10 -15 min postinduction) both head and Y-piece ET co2 and ET sevo were recorded every 15 min.
Statistical Analysis
In adults, 6 the airway sealing pressures for CobraPLA and LMAU are reported to be 23 Ϯ 6 and 18 Ϯ 5 cm H 2 O, respectively. In order to have 90% power to detect a difference in airway sealing pressures of 5 cm H 2 O between the two devices, we needed to study 25 patients per group for each of device size. Consequently, we recruited 200 patients (100 patients/ device with 25/size).
Morphometric and anesthetic data were analyzed using Student's t-test. The numbers of failed device insertions were compared with a Fisher's exact test. For the major outcomes, the patients in the two groups were subdivided post hoc into four groups: small CobraPLA (CobraPLA sizes 0.5 and 1), small LMAU (LMAU sizes 1 and 1.5), large Cobra PLA (CobraPLA sizes 1.5 and 2), and large LMAU (LMAU sizes 2 and 2.5). Analysis of variance was used for continuous measurements and 2 tests for dichotomous values. Differences in anatomical fit between the CobraPLA group and LMAU group immediately after induction of anesthesia and before emergence were analyzed using Wilcoxon Signed Rank Test. The ET (co 2 
RESULTS
There were no significant differences with regard to morphometric or anesthetic data ( Table 1 ), except that the surgery and, hence anesthesia, lasted longer in the patients who received the CobraPLA: 62 Ϯ 32 vs 50 Ϯ 27 min, P ϭ 0.006. First-attempt device insertion was successful in 95% of patients with a CobraPLA, and in 96% with an LMAU. However, the cumulative insertion success rate increased to 99% for both devices after the second attempt. Four patients in the CobraPLA group and three in the LMAU group required two attempts at insertion. One patient in each group required three attempts at insertion.
Major Outcomes
There were no significant differences between the CobraPLA and LMAU groups in the time and ease of insertion or the number of attempts required for successful insertion (Table 1) . However, insertion times were significantly shorter with the smaller airway devices in both CobraPLA and LMAU (Table 2) .
Anatomical fit was assessed in 33 CobraPLA patients and 30 LMAU patients. The fiberoptic view was significantly better (scores 3-4) in the CobraPLA group than in the LMAU group both immediately after induction and before emergence (P Ͻ 0.001). The overall fit was judged worse before emergence than after induction in the LMAU subgroups (scores 1-2) as compared with the CobraPLA subgroups in which there was no change (Table 2 ). This suggests that CobraPLA was more stable in the airway than the LMAU. The fiberoptic examination revealed no epiglottic down-folding or laryngeal view obstruction in the CobraPLA group, whereas in the LMAU group epiglottic down-folding and laryngeal view obstruction occurred in two patients after induction and in six patients before emergence. (Fig. 2) . In contrast, at inflation pressures of both 40 and 60 cm H 2 O, the airway sealing pressures were similar in the small and large LMAU groups. The peak airway pressure at 20 min was significantly smaller in the large LMAU subgroup than in any of the other three subgroups ( Table 2) .
The incidences of complications (laryngospasm, bronchospasm, blood staining on the device, sore throat, and dysphagia) were similar in the four subgroups. The volume of stomach gas aspirated was significantly smaller (P Ͻ 0.001) in patients having a CobraPLA (0.6 mL/kg) than in those given a LMAU (1.3 mL/kg). In addition, children in the large LMAU subgroup had a larger stomach gas volume than did children in the other subgroups (Table 2 ). There was neither difficulty nor apparent trauma with the OGT placement.
In two patients in each device group (one each with the CobraPLA 1 and 1.5, LMAU 1 and 1.5) placement of the device failed due to either laryngospasm or bronchospasm. Three of the patients' tracheas were intubated after the second attempt at placing the extraglottic device. In one case, the patient's trachea was intubated only after three failed insertion attempts with the assigned device (LMAU) and an additional failed attempt with a CobraPLA. None of these four patients had any additional complications. 
Ventilation
Data for ET co2 and ET sevo were collected from 44 patients with all sizes of the CobraPLA used in the study (size 0.5 n ϭ 10; size 1 n ϭ 11; size 1.5 n ϭ 13; size 2 n ϭ 10). Measurements in an additional six patients were abandoned due to sample line obstruction. The mean (Ϯ sd) measurement times were 48 Ϯ 17, 45 Ϯ 12, 38 Ϯ 14, and 57 Ϯ 17 min for CobraPLA sizes 0.5, 1, 1.5, and 2, respectively.
Linear regression and the Bland Altman plot for ETco 2 are presented in Figures 3 and 4 . Linear regression between the measurement sites for ET co2 indicated that the values at the Y-piece site were more than that at the head site (Proximal measurement ϭ 
Ͻ0.001
Data presented as means Ϯ SD s or counts.
For post hoc tests, the letters "a", "b", and "c" are used to designate which groups are similar and which are different. Groups that share the same letter are considered to NOT be statistically different from each other. d Ease of insertion graded as 1 ϭ smooth insertion without any need for adjustment; 2 ϭ need for at least one adjustment maneuver; 3 ϭ more than one adjustment maneuver required to obtain optimal positioning. 
DISCUSSION
Our results show that the CobraPLA airway performs as well as the LMAU Classic during anesthesia in pediatric patients for a large range of outcomes and out-performed the LMAU for others. We could only partially confirm previous reports in adults that the CobraPLA provides superior sealing pressures to LMAU during controlled ventilation. 6, 14 Overall, there were no significant differences between the sealing pressures in the two airway groups at 40 or 60 cm H 2 O; however, subgroup analysis revealed that the sealing pressures in the large CobraPLA subgroups (1.5 and 2) were more than those of the small CobraPLA subgroup (0.5 and 1) and the large LMAU subgroup (2 and 2.5) at both inflation pressures. The lack of an increased sealing pressure in pediatric patients receiving the small CobraPLA sizes might have been the result of a difference in the anatomical shape of the pharynx in infants versus older children and adults. In fact, Arens et al. 15 assessed the airway dimensions of children aged 1 to 11 yr by magnetic resonance imaging and found a linear increase in the upper airway dimensions with age. They concluded that soft tissues surrounding the upper airway, including tonsils and adenoids, grow proportionally to the skeletal structures.
Sealing pressures were measured at two different cuff inflation pressures: 40 and 60 cm H 2 O. In adults 70 cm H 2 O (range, 51-92) intracuff pressure in a cuffed oropharyngeal airway generated a mucosal pressure of 56 cm H 2 O (range, 22-87). With increased intracuff pressure, mucosal blood flow decreases progressively until it is abolished at mucosal pressures more than 80 cm H 2 O. 16 The 60 cm H 2 O inflation pressure is, however, higher than the mean arterial blood pressure of children and infants, and thus we selected a second lower cuff inflation pressure below this range (40 cm H 2 O). No data are available on the optimal cuff pressure to preserve pharyngeal mucosal blood flow in infants and children. We assumed that if sealing were effective at 40 cm H 2 O the side effects of higher inflation pressures (e.g., sore throat) would be minimized. The sealing pressures at 40 and 60 cm H 2 O cuff inflation were similar. Age is often reported as a risk factor for complications during pediatric anesthesia. 17 In a survey of 9289 anesthetics in patients younger than 62 mo, the incidence of airway complications were related to age. 18 Our study was not powered to confirm these results, especially as complications other than sore throat and dysphonia were uncommon.
LMAU use in infants has been limited due to the relatively frequent incidence of airway complications associated with the size 1 LMAU. 19 -21 One study found a 22% incidence of airway complications when the LMAU 1 was used. 20 Bagshaw 22 reported a complication rate of 42% with the use of a size 1.5 LMAU with complications more common in younger patients. Positioning the size 1 LMAU was also found to be difficult and resulted in respiratory complications in 30% of the patients. 17 In 6% of patients, the device functioned inadequately with insertion followed by delayed airway obstruction in 24% of children. 16 Others report similar difficulties with small sizes of LMAUs. 23 These problems resulted from distortion of the airway with epiglottic down-folding that might have contributed to the partial upper airway obstruction. 17 Once in place, accidental dislodgement of the LMAU can occur, but this is considered a minor complication if the patient's airway is accessible. 23 Distortion of the LMAU by epiglottic down-folding occurs in as many as 90% of children after the insertion of sizes 2 and 2.5 LMAUs; this might contribute to partial upper airway obstruction. 17, 24 Usually, this does not affect the device's functionality with spontaneous breathing but it can cause difficulties with positive pressure ventilation and it may hamper intubation through an LMAU.
Epiglottic folding causing partial or complete obstruction was also found in 77% of patients 10 kg and undermanaged with CobraPLA. 25 In marked contrast, we did not observe laryngeal view obstruction by the epiglottis in the CobraPLA group. In the LMAU group, however, there were two cases with epiglottis down-folding after induction and six before emergence, which indicated the tendency for the position of LMAU to shift during anesthesia. As in other studies this shift in LMAU position did not seriously affect ventilation. 17 The success rate at first and second attempts was more than 95% and 99% respectively with both airways. This contrasts with earlier reports of a 90% 26 and 86% 24 success rate for LMAU placement at first attempt with only a 97% success rate by the third attempt. The fit and sealing characteristics of CobraPLA (1.5 and 2) in mechanically ventilated children were found adequate in 90% of cases at the first attempt and 97.5% at the second attempt. 27 We found the CobraPLA to be more stable than the LMAU. The apparent stability of the CobraPLA can be attributed to its wide, flat distal head, which is rigid enough to prevent rotation of the device. The better anatomical fit of the CobraPLA becomes especially important if fiberoptic intubation through the device is needed. 8, 10 Distension of the stomach can lead to pulmonary embarrassment by splinting the diaphragm and could predispose reflux and pulmonary aspiration of gastric contents. The incidence of gastroesophageal insufflation during use of the LMAU, assessed qualitatively, depends on airway pressure and is reported to range from 0% 28 to 35%. 29 In a previous study, LMAU malposition increased the chance of gastric insufflation from 3% to 19%. 30 Our CobraPLA patients had less gastric volume than those in the LMAU group which may have related to a better anatomical fit with the CobraPLA. Nitrous oxide was administered at the same concentration in all patients, and its influence on cuff pressure was limited by monitoring and maintaining cuff pressure at 40 mm Hg. Nonetheless, patients in the CobraPLA group had a slightly longer anesthesia time and less gastric distention than the LMAU group.
A limitation is that we measured gastric volume by OGT aspiration. Although gastric volume has been measured this way in previous studies, 23 ,31 the method can be inaccurate. Gastric volume can be qualitatively assessed by epigastric auscultation, [32] [33] [34] since as little as 5 mL of gas entering the stomach can be detected by this method. 35 In one study, for children managed with a LMAU, the stomach gas volume measured by auscultation was reportedly lower (0.22 Ϯ 0.25 mL/kg) 26 than in our patients (1.3 mL/kg). This difference may have been that we aspirated the stomach after we performed the airway sealing measurements and then removed the OGT; at the end of anesthesia we reinserted the OGT. Our measured gas volume thus reflected the gas volume leaked into the stomach during surgery. In contrast, an OGT left in situ, as in previous studies, may allow some air to escape around it.
Previous work suggests that the small tidal volumes in infants make ETco 2 measurements at the Y-piece piece of the circle system inaccurate compared with measurements at the end of an endotracheal tube. 36 Our results support this assertion, as values were greater (and presumably more accurate) at the head of the CobraPLA. The difference was 6.4 Ϯ 6 mm Hg which could be clinically important. The substantial differences found between ET CO2 concentrations at the Cobra PLA's head and the circuit Y-piece in children up to 30 kg suggest that CobraPLA head gas sampling is potentially beneficial in most pediatric patients, not just infants. It remains unclear whether this difference results only from increased dead-space or if a leak around the CobraPLA may have also contributed.
In summary, the CobraPLA performed as well as the LMAU Classic during anesthesia in infants and children but proved superior with regards to the anatomical fit and stability within the airway. The CobraPLA also produced less gastric insufflation. In infants, the distal site sampling of ET co2 with the CobraPLA may be more accurate than the standard measurement site at the Y-piece piece of the anesthesia circuit.
